Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 17,845 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Patient Control Clear all

Conditions: Heart Failure
Interventions: Apixaban, Warfarin, LVAD implant; Drug · Device
Lead sponsor: Palak Shah; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Minimally Invasive Surgery, Hysterectomy, Postoperative, Satisfaction
Interventions: postoperative follow up appointment; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Diabetes Mellitus, Type 2, Hypertension
Interventions: Carvedilol Controlled Release (CR), lisinopril; Drug
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 70 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Mild Cognitive Impairment
Interventions: CRT, CBT, Modifiable lifestyle factors, Usual care Psychoeducation; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Kidney Disease
Interventions: BAY3283142, Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 1,222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 24
States / cities: Huntsville, Alabama • Chula Vista, California • San Dimas, California + 20 more

Conditions: Glenoid Labrum Tear
Interventions: BFR, Standard Rehabilitation; Device · Other
Lead sponsor: Andrews Research & Education Foundation; Other
Eligibility: 18 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Gulf Breeze, Florida

Conditions: IgA Nephropathy, Immunoglobulin A Nephropathy
Interventions: Atrasentan, Placebo, Zigakibart; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 404 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 21
States / cities: Birmingham, Alabama • Alhambra, California • Glendale, California + 18 more

Conditions: Amputation of Knee, Back Pain, Osteo Arthritis Knee
Interventions: Haptic Biofeedback from SageMotion Biofeedback System; Device
Lead sponsor: San Jose State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Palo Alto, California • San Francisco, California

Conditions: Gastric Ultrasound, Glucagon-like Peptide 1, Point of Care Ultrasound
Interventions: Gastric Ultrasound Exam; Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 99 Years
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Jacksonville, Florida • Albany, New York + 2 more

Conditions: Parkinson's Disease
Interventions: NR2B NMDA Antagonist CP-101,606 (traxoprodil); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Recruitment
Interventions: Baseline (control) message, Positively-valenced message, Payment-inclusive message, Positively-valenced, payment-inclusive message; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Disease of Liver and Bile Duct
Interventions: vibration controlled transient elastography (VCTE); Procedure
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Solid Tumor, Adult, Healthy Donors, COVID-19 Donors
Interventions: Not listed
Lead sponsor: BioCytics, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Huntersville, North Carolina

Conditions: Arthritis
Interventions: Live Music Therapy, Recorded Music Therapy, Control; Other
Lead sponsor: April Armstrong; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Post-operative Pain, Post-operative Nausea and Vomiting, Respiratory Depression, Confusion Postoperative
Interventions: ComfortSafe Care; Procedure
Lead sponsor: Georgetown University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Heart Failure
Interventions: HF training, No HF training; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 20 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Colorectal Cancer
Interventions: mHealth for Colorectal cancer screening in Homeless Persons, Control SMS Messages; Behavioral · Other
Lead sponsor: George Washington University; Other
Eligibility: 45 Years to 75 Years
Enrollment: 588 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Alcohol Dependence, Chronic Hepatitis C
Interventions: Motivational Enhancement Therapy (MET), Health education; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Portland, Oregon

Conditions: HIV
Interventions: Care management; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Blood Flow Restriction
Interventions: Blood Flow Restriction Therapy, Traditional Therapy; Device · Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: COVID-19
Interventions: LY3819253, Placebo, Remdesivir; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 42
States / cities: Tucson, Arizona • Fresno, California • Los Angeles, California + 32 more

Conditions: Sepsis, Sepsis and Septic Shock, Sepsis With Multiple Organ Dysfunction (MOD), Sepsis With Acute Organ Dysfunction, Sepsis, Severe, Sepsis at Intensive Care Unit, Sepsis, Severe Sepsis and Septic Shock, Sepsis, Septic Shock
Interventions: RNA and DNA Sequencing; Genetic
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Knee Osteoarthritis
Interventions: Microfragmented Adipose Tissue (Lipogems), Corticosteroid injection, Saline; Device · Drug
Lead sponsor: Dustin L. Richter, MD; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Labor
Interventions: Ephedrine, Normal Saline Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices

Patient Satisfaction With Postoperative Follow up After Minimally Invasive Hysterectomy

Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.

Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

Blood Flow Restriction Training Following Glenoid Labral Repair

Atrasentan in Patients With IgA Nephropathy

Biofeedback Retention in Individuals With AKA

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease

Optimizing Strategies to Maximize Patient Recruitment Yield

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

The Effect of Music Therapy Intervention on Pain and Anxiety in Adult Patients Undergoing Total Shoulder Arthroplasty

Multimodal Perioperative Pain Management: ComfortSafe Program

"Hub and Satellite" Heart Failure Provider's Network Study

Colorectal Cancer Screening in the Homeless

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care

BFR Therapy in Patients With Rotator Cuff Tears

LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Role of Transposable Elements in Septic Immune Aging

Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE